Chao Zheng

Research Synopsis

The Zheng research group focuses on the development and application of innovative radiopharmaceuticals for the diagnosis and assessment of treatment in neuropsychiatric and neurodegenerative disorders. Dr. Chao Zheng’s research program has specific objectives: 1) Discovery of cutting-edge radiopharmaceuticals for brain imaging applications; 2) Developing and applying novel PET imaging methods that directly capture biochemical or phenotypic changes in vivo. This involves integrating disciplines such as medicinal chemistry, radiochemistry, quantitative PET imaging from in vitro and preclinical in vivo studies, and pharmacology. This excellent research opportunity will provide extensive training in radiochemistry and PET neuroimaging in a preclinical and clinical research environment.